83 related articles for article (PubMed ID: 10210594)
1. Semi-quantitative analysis of telomerase activity in human urothelial cells and bladder transitional cell carcinoma.
Mayfield MP; Bibby MC
BJU Int; 1999 Mar; 83(4):528-9. PubMed ID: 10210594
[No Abstract] [Full Text] [Related]
2. Telomerase: a potential marker of bladder transitional cell carcinoma in bladder washes.
Lee DH; Yang SC; Hong SJ; Chung BH; Kim IY
Clin Cancer Res; 1998 Mar; 4(3):535-8. PubMed ID: 9533519
[TBL] [Abstract][Full Text] [Related]
3. [Quantitative analysis of telomerase activity in exfoliated urothelial cells for the diagnosis of bladder carcinoma].
Yokota K; Kanayama H; Kagawa S; Abe-Hashimoto J; Hirose M; Yoshimura T
Nihon Rinsho; 1998 May; 56(5):1292-8. PubMed ID: 9613140
[TBL] [Abstract][Full Text] [Related]
4. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Bian W; Xu Z
Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
[TBL] [Abstract][Full Text] [Related]
5. A comparison of BTA stat, hemoglobin dipstick, telomerase and Vysis UroVysion assays for the detection of urothelial carcinoma in urine.
Halling KC; King W; Sokolova IA; Karnes RJ; Meyer RG; Powell EL; Sebo TJ; Cheville JC; Clayton AC; Krajnik KL; Ebert TA; Nelson RE; Burkhardt HM; Ramakumar S; Stewart CS; Pankratz VS; Lieber MM; Blute ML; Zincke H; Seelig SA; Jenkins RB; O'Kane DJ
J Urol; 2002 May; 167(5):2001-6. PubMed ID: 11956427
[TBL] [Abstract][Full Text] [Related]
6. The role of urine cytology in the assessment of lower urinary tract symptoms.
Kouriefs C; Leris AC; Mokbel K; Carpenter R
BJU Int; 2000 Jun; 85(9):1155. PubMed ID: 10939871
[No Abstract] [Full Text] [Related]
7. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma.
Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S
Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590
[TBL] [Abstract][Full Text] [Related]
8. A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer.
Bowles L; Bialkowska-Hobrzanska H; Bukala B; Nott L; Razvi H
Can J Urol; 2004 Dec; 11(6):2438-44. PubMed ID: 15636669
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
Xie XY; Yang X; Zhang JH; Liu ZJ
Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
[TBL] [Abstract][Full Text] [Related]
10. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay.
Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C
Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723
[TBL] [Abstract][Full Text] [Related]
11. [HIV-infected patient with macrohematuria. Urothelial carcinoma of the urinary bladder].
Wolf K
Praxis (Bern 1994); 2001 Jun; 90(25-26):1159-61. PubMed ID: 11469059
[No Abstract] [Full Text] [Related]
12. [Detection of urothelial carcinoma of the urinary bladder by multicolor fluorescence in situ hybridization].
Zhang YG; Bi XG; Han YL; Cai Y; Xu X; Wu YP; Yang YL; Ma JH; Zhao P; Jia XM; Wang MR
Ai Zheng; 2007 Feb; 26(2):189-93. PubMed ID: 17298751
[TBL] [Abstract][Full Text] [Related]
13. Detection of human telomerase RNA in the tumour-surrounding mucosa of bladder carcinomas as a marker for premalignant transformation.
Leuenroth S; Riethdorf S; Erbersdobler A; Riethdorf L; Löning T; Huland H; Friedrich MG
BJU Int; 2005 Sep; 96(4):553-7. PubMed ID: 16104909
[TBL] [Abstract][Full Text] [Related]
14. Argon laser induced autofluorescence may distinguish between normal and tumor human urothelial cells: a microspectrofluorimetric study.
Anidjar M; Cussenot O; Blais J; Bourdon O; Avrillier S; Ettori D; Villette JM; Fiet J; Teillac P; Le Duc A
J Urol; 1996 May; 155(5):1771-4. PubMed ID: 8627881
[TBL] [Abstract][Full Text] [Related]
15. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
16. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.
Skacel M; Fahmy M; Brainard JA; Pettay JD; Biscotti CV; Liou LS; Procop GW; Jones JS; Ulchaker J; Zippe CD; Tubbs RR
J Urol; 2003 Jun; 169(6):2101-5. PubMed ID: 12771727
[TBL] [Abstract][Full Text] [Related]
17. Expression of the human mismatch repair gene hMSH2: a potential marker for urothelial malignancy.
Leach FS; Hsieh JT; Molberg K; Saboorian MH; McConnell JD; Sagalowsky AI
Cancer; 2000 May; 88(10):2333-41. PubMed ID: 10820356
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise.
Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A
J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230
[TBL] [Abstract][Full Text] [Related]
19. MR imaging of the urinary bladder.
Barentsz JO; Jager GJ; Witjes JA
Magn Reson Imaging Clin N Am; 2000 Nov; 8(4):853-67. PubMed ID: 11149683
[No Abstract] [Full Text] [Related]
20. Telomerase activity in urine in diagnosis and recurrence surveillance of urothelial carcinoma.
Li Z; Kong C; Wang P; Liu X; Liu T
Chin Med J (Engl); 2002 Nov; 115(11):1650-2. PubMed ID: 12609080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
